Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI₂) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study

Ioana R. Preston, Richard N. Channick, Kelly Chin, Lilla Di Scala, Harrison W. Farber, Sean Gaine, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Irene M. Lang, Vallerie V. McLaughlin, Ralph Preiss, Ge´rald Simonneau, Olivier Sitbon, Victor F. Tapson, Lewis J. Rubin